How congressional leadership changes could impact supplement industry

The House Committee with jurisdiction over FDA will likely see a leadership role reversal, writes AHPA President Michael McGuffin.

Related Keywords

United States ,American ,Rob Portmanr Ohio ,Cassidyr Louisiana ,Dick Durbind Illinois ,Donald Trump ,Bernie Sandersi Vermont ,Anthony Fauci ,John Curtisr Utah ,Paulr Kentucky ,Patty Murrayd Washington ,Cathy Mcmorris Rodgersr Washington ,Pete Evich ,Brett Guthrier Kentucky ,Patrick Leahyd Vermont ,Senate Appropriations Committee ,Committee On ,National Institute Of Allergy ,House Ec Committee ,Commerce Ec Committee ,Drug Administration Safety ,Republican Committee ,Ec Health Subcommittee ,Senate Homeland Security Committee ,American Herbal Products Association ,White House Coronavirus Task Force ,Us Senate ,House Energy ,Congress On Regulatory Priorities ,Committee Is Sen ,Senate Health ,Patrick Leahy ,Patty Murray ,Senate Appropriations ,Federal Food ,Cosmetic Act ,Dick Durbin ,Bernie Sanders ,Landmark Advancements Act ,Richard Burr ,R North Carolina ,Rand Paul ,National Institute ,Infectious Diseases ,President Donald Trump ,Rob Portman ,Should Paul ,Senator Bill Cassidy ,Frank Pallone ,D New Jersey ,Cathy Mcmorris Rodgers ,Should Democrats ,John Curtis ,Congressional Dietary Supplement Caucus ,Brett Guthrie ,Health Subcommittee ,Congressional Dietary Supplement ,While Pallone ,Whether Democrats ,Regulatory Priorities ,Natural Products Market ,